| Primary |
| Hormone Replacement Therapy |
100.0% |
|
| Phlebitis Superficial |
100.0% |
|
| Secondary |
| Hormone Replacement Therapy |
69.3% |
| Menopausal Symptoms |
7.0% |
| Drug Use For Unknown Indication |
5.9% |
| Menopause |
5.9% |
| Osteoporosis |
2.6% |
| Oestrogen Replacement Therapy |
1.9% |
| Postmenopause |
1.9% |
| Depression |
1.1% |
| Intentional Overdose |
1.1% |
| Growth Hormone Deficiency |
0.7% |
| Hysterectomy |
0.7% |
| Ill-defined Disorder |
0.7% |
| Blood Cholesterol Abnormal |
0.4% |
| Fibromyalgia |
0.4% |
| Night Sweats |
0.4% |
|
| Breast Cancer |
69.1% |
| Breast Cancer Female |
8.1% |
| Weight Increased |
3.3% |
| Breast Disorder |
2.4% |
| Thrombosis |
2.4% |
| Cerebrovascular Accident |
1.6% |
| Myocardial Infarction |
1.6% |
| Ovarian Cancer |
1.6% |
| Breast Cancer Stage Ii |
0.8% |
| Breast Tenderness |
0.8% |
| Deep Vein Thrombosis |
0.8% |
| Endometrial Cancer |
0.8% |
| Female Sexual Arousal Disorder |
0.8% |
| Hot Flush |
0.8% |
| Irritable Bowel Syndrome |
0.8% |
| Oestrogen Receptor Assay Positive |
0.8% |
| Pain |
0.8% |
| Pain In Extremity |
0.8% |
| Progesterone Receptor Assay Positive |
0.8% |
| Pulmonary Embolism |
0.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
10.1% |
| Depression |
7.8% |
| Osteoporosis |
7.8% |
| Hypertension |
7.3% |
| Multiple Sclerosis |
7.3% |
| Rheumatoid Arthritis |
7.3% |
| Fibromyalgia |
6.7% |
| Insomnia |
5.0% |
| Pain |
5.0% |
| Premedication |
5.0% |
| Hormone Replacement Therapy |
4.5% |
| Non-small Cell Lung Cancer |
4.5% |
| Asthma |
3.4% |
| Hepatitis C Virus |
3.4% |
| Migraine |
3.4% |
| Restless Legs Syndrome |
2.8% |
| Back Pain |
2.2% |
| Bronchitis |
2.2% |
| Chronic Fatigue Syndrome |
2.2% |
| Convulsion |
2.2% |
|
| Pain |
11.9% |
| Weight Increased |
11.9% |
| Nausea |
7.5% |
| Somnolence |
7.5% |
| Insomnia |
6.0% |
| Vision Blurred |
6.0% |
| Pharmaceutical Product Complaint |
4.5% |
| Thinking Abnormal |
4.5% |
| Tooth Abscess |
4.5% |
| Weight Decreased |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Breast Cancer |
3.0% |
| Cerebrovascular Disorder |
3.0% |
| Chronic Lymphocytic Leukaemia |
3.0% |
| Coronary Artery Disease |
3.0% |
| Drug Ineffective |
3.0% |
| Dysgeusia |
3.0% |
| Gastric Cancer |
3.0% |
| Hypersensitivity |
3.0% |
| Malaise |
3.0% |
|
